Related Experiment Videos

Downregulation of insulin receptors in obese man

Diabetes
|April 1, 1979
PubMed

Insights

Diazoxide treatment in obese individuals revealed that reduced insulin receptors are likely due to downregulation, not the primary cause of insulin resistance. Some subjects showed increased insulin receptor numbers after treatment.

Area of Science:

  • Metabolism and Endocrinology
  • Molecular Biology

Background:

  • Obesity is often associated with insulin resistance and a decreased number of insulin receptors.
  • The precise mechanism behind reduced insulin receptor numbers in obesity remains under investigation, with receptor downregulation being a key hypothesis.

Purpose of the Study:

  • To investigate whether the diminished insulin receptor count in obese individuals is a consequence of receptor downregulation.
  • To assess the impact of pharmacologically suppressing insulin levels on insulin receptor numbers and glucose tolerance.

Main Methods:

  • Diazoxide was administered at 5 mg/kg/d to 10 obese subjects.
  • Insulin receptor studies were conducted using Scatchard plot analysis before and after diazoxide treatment.
  • Changes in both high-affinity and low-affinity insulin receptors were evaluated.

Main Results:

  • Diazoxide administration led to mild glucose intolerance and an increase in insulin receptors in 7 out of 10 subjects.
  • Subjects were categorized into three groups based on receptor response: increased high and low affinity receptors (4 subjects), increased high-affinity receptors only (3 subjects), and no change (3 subjects).

Conclusions:

  • The findings support the hypothesis that reduced insulin receptor numbers in obesity result from receptor downregulation.
  • Receptor downregulation is suggested to be a consequence rather than the primary cause of insulin resistance in obesity, though it may contribute.
  • Individual variations in receptor response to insulin suppression were observed.

Related Concept Videos